OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC327173 Human cDNA pCMV6-XL5 SCNN1A (untagged)-Human sodium channel nonvoltage-gated 1 alpha (SCNN1A) transcript variant 3 NM_001159575.1 $1290 2-3 weeks
RC228538 Human ORF PS100001 SCNN1A (Myc-DDK-tagged)-Human sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 3 $1030 Immediate
RC228538L1 Human ORF PS100064 Lenti-ORF clone of SCNN1A (Myc-DDK-tagged)-Human sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 3, (10ug) $1200 4-5 weeks
RC228538L1V Human ORF PS100064 Lenti ORF particles, SCNN1A (Myc-DDK-tagged)-Human sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 3, 0.5 mL, >10^6 TU/mL $1600 7-8 weeks
RC228538L2 Human ORF PS100071 Lenti-ORF clone of SCNN1A (mGFP-tagged)-Human sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 3, (10ug) $1320 4-5 weeks
RC228538L2V Human ORF PS100071 Lenti ORF particles, SCNN1A (mGFP-tagged)-Human sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 3, 0.5 mL, >10^6 TU/mL $1760 7-8 weeks
RG228538 Human ORF PS100010 SCNN1A (GFP-tagged) - Human sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 3 $1130 98-99 weeks
LY431566 Lysate LC431566 Transient overexpression lysate of sodium channel, nonvoltage-gated 1 alpha (SCNN1A), transcript variant 3 $480 5 days
/ UTR pMirTarget 3`UTR clone of sodium channel nonvoltage-gated 1 alpha (SCNN1A) transcript variant 3 for miRNA target validation NM_001159575.1 $510 3-4 weeks
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title